View All Blog Posts

Health Forward Statement on COVID-19

As the global community grapples with COVID-19, the novel strain of coronavirus, reports confirm that cases in the Middle East and North Africa (MENA) continue to rise. Our thoughts are with those affected both in the region and around the world.

The rapid spread of the coronavirus is a major public health threat. The science needed to tackle the challenge presented by COVID-19 will require global partnerships. Stakeholders, in both the public and private sectors, are collaborating to develop timely treatments and vaccines. In the face of global health threats, policies that support innovation are as important as ever.

Working together, we will continue to drive health forward and help treat and prevent the further spread of COVID-19. For more information about inventors of new medicines and vaccines are responding to the coronavirus crisis, please visit the International Federation of Pharmaceutical Manufacturers and Associations and the Pharmaceutical Research and Manufacturers of America.


Global Investments in Science and Innovation were Resilient during COVID-19

A new report, Global Innovation Index 2022, from the World Intellectual Property Organization (WIPO) indicates that research and development (R&D) investments thrived at the height of the COVID-19 pandemic in 2020 and continued to boom in 2021. This spike in innovation occurred despite the global recession and economic lockdowns in many countries, pointing to the importance of innovation for pandemic solutions and recovery.

Partnerships Are Bringing Lifesaving Treatments To The Middle East And North Africa

As the world prepares for future public health threats to emerge, it’s imperative public and private sector leaders are collaborating to address these challenges with innovative treatments and solutions.

Opportunities for Progress

Explore policy-related opportunities for governments, health officials and companies operating in the MENA health sector.

Learn more